1. Home
  2. PRAX vs KMX Comparison

PRAX vs KMX Comparison

Compare PRAX & KMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$254.33

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Logo CarMax Inc

KMX

CarMax Inc

HOLD

Current Price

$51.35

Market Cap

7.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
KMX
Founded
2015
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
7.6B
IPO Year
2020
2002

Fundamental Metrics

Financial Performance
Metric
PRAX
KMX
Price
$254.33
$51.35
Analyst Decision
Strong Buy
Hold
Analyst Count
21
20
Target Price
★ $650.00
$63.77
AVG Volume (30 Days)
481.4K
★ 2.9M
Earning Date
11-04-2026
09-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 2.47
Revenue
N/A
★ $25,881,131,000.00
Revenue This Year
N/A
$4.58
Revenue Next Year
$39,256.17
$1.26
P/E Ratio
★ N/A
$21.36
Revenue Growth
N/A
★ N/A
52 Week Low
$154.46
$30.26
52 Week High
$392.70
$65.28

Technical Indicators

Market Signals
Indicator
PRAX
KMX
Relative Strength Index (RSI) 38.28 41.29
Support Level $237.78 $49.21
Resistance Level $356.02 $54.22
Average True Range (ATR) 12.32 1.97
MACD 2.23 0.10
Stochastic Oscillator 32.24 31.85

Price Performance

Historical Comparison
PRAX
KMX

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About KMX CarMax Inc

CarMax sells, finances, and services used and new cars through a chain of over 255 retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales were 80% of fiscal 2026 revenue and wholesale about 17%, with the remaining portion composed of extended service plans and repair. In fiscal 2026, the company retailed and wholesaled 780,684 and 538,203 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US, but still estimates that it had only about 3.6% US market share of vehicles zero to 10 years old in calendar 2025. CarMax is based in Richmond, Virginia.

Share on Social Networks: